![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Cardinal Signs Agreement With Oncology Group
Cardinal Signs Agreement With Oncology Group
April 19, 2005
Cardinal Health Inc. has signed up as the preferred distributor of oncology
drugs for the National Oncology Alliance. The alliance, a buying group of 3,500
oncologists, operates as a subsidiary of Broadlane Inc., a San Francisco-based
company that provides business consulting to healthcare organizations. Cardinal,
a Dublin-based healthcare giant, will fill orders through its Specialty Pharmaceutical
Distribution group.
Columbus
Business First
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct